Starting October 6, ring users in the EU, UK, Canada, Australia and more can log doses, side effects and weight alongside sleep and activity data.
Recap by typeshit. Full story at Oura Ring.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
She says the cause is a calorie surplus: some patients still manage high calorie foods and aren't exercising enough while on the drugs.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
Lab scientists explain how they tell deamidation and racemization byproducts apart from the main drug, using high-resolution MS and 2D-LC.
People with conditions the drugs are approved to treat get sent back to Part D, where copays can hit $200 to $600 a month. One New Jersey patient was rejected despite a BMI of 42.
Loading…